Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97


Death receptor ligation or exposure to perforin trigger rapid egress of the intracellular parasite Toxoplasma gondii.

Persson EK, Agnarson AM, Lambert H, Hitziger N, Yagita H, Chambers BJ, Barragan A, Grandien A.

J Immunol. 2007 Dec 15;179(12):8357-65.


Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis.

Nash PB, Purner MB, Leon RP, Clarke P, Duke RC, Curiel TJ.

J Immunol. 1998 Feb 15;160(4):1824-30.


CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.

Hakim FT, Gazzinelli RT, Denkers E, Hieny S, Shearer GM, Sher A.

J Immunol. 1991 Oct 1;147(7):2310-6.


Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes.

Lowin B, Mattman C, Hahne M, Tschopp J.

Int Immunol. 1996 Jan;8(1):57-63.


Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites.

Dotiwala F, Mulik S, Polidoro RB, Ansara JA, Burleigh BA, Walch M, Gazzinelli RT, Lieberman J.

Nat Med. 2016 Feb;22(2):210-6. doi: 10.1038/nm.4023. Epub 2016 Jan 11.


Toxoplasma gondii inhibits Fas/CD95-triggered cell death by inducing aberrant processing and degradation of caspase 8.

Vutova P, Wirth M, Hippe D, Gross U, Schulze-Osthoff K, Schmitz I, Lüder CG.

Cell Microbiol. 2007 Jun;9(6):1556-70. Epub 2007 Feb 9.


Functional dissection of Toxoplasma gondii perforin-like protein 1 reveals a dual domain mode of membrane binding for cytolysis and parasite egress.

Roiko MS, Carruthers VB.

J Biol Chem. 2013 Mar 22;288(12):8712-25. doi: 10.1074/jbc.M113.450932. Epub 2013 Feb 2.


Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.

Medana I, Li Z, Flügel A, Tschopp J, Wekerle H, Neumann H.

J Immunol. 2001 Jul 15;167(2):674-81.


Real-time detection of CTL function reveals distinct patterns of caspase activation mediated by Fas versus granzyme B.

Li J, Figueira SK, Vrazo AC, Binkowski BF, Butler BL, Tabata Y, Filipovich A, Jordan MB, Risma KA.

J Immunol. 2014 Jul 15;193(2):519-28. doi: 10.4049/jimmunol.1301668. Epub 2014 Jun 13.


Toxoplasma gondii: effects of exogenous nitric oxide on egress of tachyzoites from infected macrophages.

Ji YS, Sun XM, Liu XY, Suo X.

Exp Parasitol. 2013 Jan;133(1):70-4. doi: 10.1016/j.exppara.2012.10.013. Epub 2012 Oct 27.


Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells.

Persson CM, Lambert H, Vutova PP, Dellacasa-Lindberg I, Nederby J, Yagita H, Ljunggren HG, Grandien A, Barragan A, Chambers BJ.

Infect Immun. 2009 Mar;77(3):970-6. doi: 10.1128/IAI.00833-08. Epub 2009 Jan 12. Erratum in: Infect Immun. 2009 Aug;77(8):3516.


Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.

Seki N, Brooks AD, Carter CR, Back TC, Parsoneault EM, Smyth MJ, Wiltrout RH, Sayers TJ.

J Immunol. 2002 Apr 1;168(7):3484-92.


Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells.

Subauste CS, Koniaris AH, Remington JS.

J Immunol. 1991 Dec 1;147(11):3955-9.


Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes.

Melgar S, Bas A, Hammarström S, Hammarström ML.

Immunology. 2002 Aug;106(4):476-85.


Exogenous tumor necrosis factor-alpha could induce egress of Toxoplasma gondii from human foreskin fibroblast cells.

Yao Y, Liu M, Ren C, Shen J, Ji Y.

Parasite. 2017;24:45. doi: 10.1051/parasite/2017051. Epub 2017 Nov 27.


Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii.

Jordan KA, Wilson EH, Tait ED, Fox BA, Roos DS, Bzik DJ, Dzierszinski F, Hunter CA.

Infect Immun. 2009 Sep;77(9):3894-901. doi: 10.1128/IAI.00024-09. Epub 2009 Jun 15.

Supplemental Content

Support Center